RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000069.xml
Semin Liver Dis 2021; 41(02): 172-181
DOI: 10.1055/s-0041-1723032
DOI: 10.1055/s-0041-1723032
Review Article
Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective
Funding Statement The authors received no specific funding for this work.
Abstract
For patients with early-stage hepatocellular carcinoma (HCC), liver transplantation offers the best chance of cure. Over the past two decades, selection criteria to determine eligibility for liver transplantation have been constantly refined but a fair allocation strategy of liver grafts to HCC patients remains challenging. In Europe, over a dozen transplantation networks apply different liver transplantation criteria for HCC patients. In this review, we explore and compare candidate selection and liver graft allocation strategies for patients with HCC with a European perspective and discuss the ethical and technical challenges involved. In addition, we suggest possible paths for future improvement such as transitioning from fixed selection and allocation criteria to a more flexible model of benefit, which includes criteria concerning the graft, response to treatment, the biology of the tumor, and other relevant recipient factors.
Publikationsverlauf
Artikel online veröffentlicht:
06. Mai 2021
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Mehta N, Guy J, Frenette CT. et al. Excellent outcomes of liver transplantation following down-staging of hepatocellular carcinoma to within Milan criteria: a multicenter study. Clin Gastroenterol Hepatol 2018; 16 (06) 955-964
- 2 Mazzaferro V, Sposito C, Zhou J. et al. Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma. Gastroenterology 2018; 154 (01) 128-139
- 3 Mazzaferro V, Regalia E, Doci R. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334 (11) 693-699
- 4 Yao FY, Ferrell L, Bass NM. et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33 (06) 1394-1403
- 5 Mazzaferro V, Llovet JM, Miceli R. et al; Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10 (01) 35-43
- 6 Toso C, Trotter J, Wei A. et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2008; 14 (08) 1107-1115
- 7 Wee A. Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations. Pathol Res Int 2011; 2011: 587936
- 8 Villanueva A. Hepatocellular carcinoma. N Engl J Med 2019; 380 (15) 1450-1462
- 9 European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236
- 10 Duvoux C, Roudot-Thoraval F, Decaens T. et al. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. Gastroenterology 2012; 143 (04) 986.e3-994.e3 ; quiz e14–15
- 11 Toso C, Meeberg G, Hernandez-Alejandro R. et al. Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: a prospective validation. Hepatology 2015; 62 (01) 158-165
- 12 Luo P, Yin P, Hua R. et al. A large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology 2018; 67 (02) 662-675
- 13 Bai DS, Zhang C, Chen P, Jin SJ, Jiang GQ. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Sci Rep 2017; 7 (01) 12870
- 14 Daniele B, Bencivenga A, Megna AS, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004; 127 (05, Suppl 1): S108-S112
- 15 Giannini EG, Marenco S, Borgonovo G. et al; Italian Liver Cancer (ITA.LI.CA) group. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. Hepatology 2012; 56 (04) 1371-1379
- 16 Otto G, Schuchmann M, Hoppe-Lotichius M. et al. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?. J Hepatol 2013; 59 (02) 279-284
- 17 Yao FY, Mehta N, Flemming J. et al. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology 2015; 61 (06) 1968-1977
- 18 Majno PE, Adam R, Bismuth H. et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226 (06) 688-701 , discussion 701–703
- 19 Tsochatzis E, Garcovich M, Marelli L. et al. Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma. Liver Int 2013; 33 (06) 944-949
- 20 Clavien P-A, Lesurtel M, Bossuyt PMM, Gores GJ, Langer B, Perrier A. OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2012; 13 (01) e11-e22
- 21 NHSBT. POLICY POL195/11: Liver transplantation: selection criteria and recipient registration. 2019 . Accessed September 17, 2020 at: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/9440/pol195_7-liver-selection-policy.pdf
- 22 Rodríguez-Perálvarez M, Gómez-Bravo MA, Sánchez-Antolín G, De la Rosa G, Bilbao I, Colmenero J. Spanish Society of Liver Transplantation (SETH)**. Expanding indications of liver transplantation in Spain: consensus statement and recommendations by the Spanish Society of Liver Transplantation. Transplantation 2020; (e-pub ahead of print)
- 23 Pommergaard HC, Rostved AA, Adam R. et al; European Liver and Intestine Transplant Association (ELITA). Locoregional treatments before liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry. Transpl Int 2018; 31 (05) 531-539
- 24 Neuberger J, Thorburn D. MELD—Moving steadily towards equality, equity, and fairness. Liver Transpl 2005; 11: 585-587
- 25 Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31 (04) 864-871
- 26 Kamath PS, Wiesner RH, Malinchoc M. et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33 (02) 464-470
- 27 Luo X, Leanza J, Massie AB. et al. MELD as a metric for survival benefit of liver transplantation. Am J Transplant 2018; 18 (05) 1231-1237
- 28 Lee J, Kim DG, Lee JY. et al. Impact of model for end-stage liver disease score-based allocation system in Korea: a nationwide study. Transplantation 2019; 103 (12) 2515-2522
- 29 Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol 2013; 59 (02) 367-374
- 30 Wiesner R, Lake JR, Freeman RB, Gish RG. Model for end-stage liver disease (MELD) exception guidelines. Liver Transpl 2006; 12 (12, Suppl 3): S85-S87
- 31 Navasa M, Bruix J. Multifaceted perspective of the waiting list for liver transplantation: the value of pharmacokinetic models. Hepatology 2010; 51 (01) 12-15
- 32 Sharma P, Harper AM, Hernandez JL. et al. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transplant 2006; 6 (08) 1957-1962
- 33 Heimbach JK. United States liver allocation. Curr Opin Organ Transplant 2020; 25 (02) 104-109
- 34 Uehlinger NB, Beyeler F, Weiss J, Marti HP, Immer FF. Organ transplantation in Switzerland: impact of the new transplant law on cold ischaemia time and organ transports. Swiss Med Wkly 2010; 140 (15–16): 222-227
- 35 Langer RM, Cohen B, Rahmel A. History of eurotransplant. Transplant Proc 2012; 44 (07) 2130-2131
- 36 Eurotransplant, Chapter 5. Eurotransplant liver allocation system. 2019 . Accessed September 17, 2020 at: https://www.eurotransplant.org/wp-content/uploads/2020/01/H5-ELAS-MELD.pdf
- 37 Jochmans I, van Rosmalen M, Pirenne J, Samuel U. Adult liver allocation in Eurotransplant. Transplantation 2017; 101 (07) 1542-1550
- 38 Umgelter A, Hapfelmeier A, Kopp W, van Rosmalen M, Rogiers X, Guba M. Eurotransplant Liver Advisory Committee. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions. Liver Transpl 2017; 23 (10) 1256-1265
- 39 Ishaque T, Massie AB, Bowring MG. et al. Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change. Am J Transplant 2019; 19 (02) 564-572
- 40 Northup PG, Intagliata NM, Shah NL, Pelletier SJ, Berg CL, Argo CK. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation. Hepatology 2015; 61 (01) 285-291
- 41 IRODaT. International Online Registry for Organ Donation and Transplantation. 2019 . Accessed September 17, 2020 at: https://www.irodat.org/
- 42 Matesanz R, Domínguez-Gil B, Coll E, Mahíllo B, Marazuela R. How Spain reached 40 deceased organ donors per million population. Am J Transplant 2017; 17 (06) 1447-1454
- 43 Organizacion nacional de trasplantes, Actividad de Donación y Trasplante Hepático e Intestinal 2019, Accessed: 21.01.2021, http://www.ont.es/infesp/Memorias/Actividad%20de%20Donaci%C3%B3n%20y%20Trasplante%20Hep%C3%A1tico%20e%20Intestinal%202019.pdf
- 44 de la Rosa G, Fondevila C, Navasa M. Liver transplantation in Spain. Liver Transpl 2016; 22 (09) 1259-1264
- 45 Llovet JM, Fuster J, Bruix J. Barcelona-Clínic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004; 10 (02, Suppl 1): S115-S120
- 46 Pardo F, Pons JA, Briceño J. en nombre de la Sociedad Española de Trasplante Hepático. V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list. Cir Esp 2015; 93 (10) 619-637
- 47 Agence de la biomedicine. Activité de greffe hépatique 2019, Accessed: 21.01.2021, https://rams.agence-biomedecine.fr/greffe-hepatique-0
- 48 Amin MB, Greene FL, Edge SB. et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017; 67 (02) 93-99
- 49 Durand F, Antoine C, Soubrane O. Liver transplantation in France. Liver Transpl 2019; 25 (05) 763-770
- 50 Angelico M, Cillo U, Fagiuoli S. et al; Liver Match Investigators. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis 2011; 43 (02) 155-164
- 51 De Carlis L, Di Sandro S, Centonze L. et al. Liver-allocation policies for patients affected by HCC in Europe. Curr Transplant Rep 2016; 3 (04) 313-318
- 52 Cillo U, Burra P, Mazzaferro V. et al; I-BELT (Italian Board of Experts in the Field of Liver Transplantation). A multistep, consensus-based approach to organ allocation in liver transplantation: toward a “blended principle model”. Am J Transplant 2015; 15 (10) 2552-2561
- 53 Vitale A, Volk ML, De Feo TM. et al; Liver Transplantation North Italy Transplant program (NITp) working group. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. J Hepatol 2014; 60 (02) 290-297
- 54 Sistema Informativo dei Trapianti, Name: Donazioni, trapianti, liste di attesa, Accessed: 21.01.2021, https://trapianti.sanita.it/statistiche/attivita/2020_F_ATTIVITA_ORGANI_DX-TX.pdf
- 55 NHSBT. Annual report on liver transplantation for 2018/2019. 2019 . Accessed September 17, 2020 at: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/16782/nhsbt-liver-transplantation-annual-report-2018-19.pdf
- 56 NHSBT. Policy POL196/7 deceased donor liver distribution and allocation. 2019 . Accessed September 17, 2020 at: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/17449/liver-allocation-policy-pol196.pdf
- 57 Surgical Informatics, University of Edinburgh, Name: Transplant Benefit Score Calculator, Accessed: 21.01.2021, https://transplantbenefit.org/
- 58 Orci LA, Lacotte S, Oldani G. et al. Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis. Br J Surg 2016; 103 (04) 417-426
- 59 Fosby B, Melum E, Bjøro K. et al. Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013. Scand J Gastroenterol 2015; 50 (06) 797-808
- 60 Dueland S, Syversveen T, Solheim JM. et al. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases. Ann Surg 2020; 271 (02) 212-218
- 61 Pomfret EA, Washburn K, Wald C. et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010; 16 (03) 262-278
- 62 Toso C, Majno P, Berney T, Morel P, Mentha G, Combescure C. Validation of a dropout assessment model of candidates with/without hepatocellular carcinoma on a common liver transplant waiting list. Transpl Int 2014; 27 (07) 686-695
- 63 Schaubel DE, Guidinger MK, Biggins SW. et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009; 9 (4, Pt 2): 970-981
- 64 Mazzaferro V. Squaring the circle of selection and allocation in liver transplantation for HCC: an adaptive approach. Hepatology 2016; 63 (05) 1707-1717
- 65 Toso C, Mazzaferro V, Bruix J, Freeman R, Mentha G, Majno P. Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma. Am J Transplant 2014; 14 (10) 2221-2227
- 66 Gimson A. Development of a UK liver transplantation selection and allocation scheme. Curr Opin Organ Transplant 2020; 25 (02) 126-131
- 67 Lai Q, Vitale A, Iesari S. et al; European Hepatocellular Cancer Liver Transplant Study Group. Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer. Hepatology 2017; 66 (06) 1910-1919
- 68 Abreu P, Gorgen A, Oldani G, Hibi T, Sapisochin G. Recent advances in liver transplantation for cancer: The future of transplant oncology. JHEP Rep 2019; 1 (05) 377-391
- 69 Halazun KJ, Tabrizian P, Najjar M. et al. Is it time to abandon the Milan criteria?: results of a bicoastal US collaboration to redefine hepatocellular carcinoma liver transplantation selection policies. Ann Surg 2018; 268 (04) 690-699
- 70 Eurotransplant. Eurotransplant Statistics Report Library. 2020 . Accessed September 17, 2020 at: https://statistics.eurotransplant.org/
- 71 Neuberger J. Liver transplantation in the United Kingdom. Liver Transpl 2016; 22 (08) 1129-1135
- 72 Registry NLT. The Nordic Liver Transplant Registry (NLTR) Annual report 2018. 2018 . Accessed September 17, 2020 at: http://www.scandiatransplant.org/members/nltr/TheNordicLiverTransplantRegistryANNUALREPORT2018.pdf
- 73 Czerwiński J, Lewandowska D, Małkowski P, Danielewicz R. Liver donation and transplantation in Poland: numbers, indicators, and trends. Transplant Proc 2016; 48 (05) 1341-1346
- 74 Poltransplant, Poltransplant Information Bulletin, Accessed: 21.01.2021, https://www.poltransplant.org.pl/aktual.html
- 75 Swisstransplant, Annual Report Swisstransplant 2018, Accessed: 21.01.2021, https://www.swisstransplant.org/fileadmin/user_upload/Swisstransplant/Jahresbericht/Jahresbericht_und_Grafiken_2018/Swisstransplant_Jahresbericht_2018.pdf
- 76 Swisstransplant, Monthly Reports: Key Figures on Organ Donation and Organ Donation, Accessed: 21.01.2021, https://www.swisstransplant.org/en/information-material/for-professionals/information-about-the-coronavirus/monthly-reports/
- 77 Popescu I, Ionescu M, Braşoveanu V. et al. The Romanian National Program for Liver Transplantation - 852 procedures in 815 patients over 17 years (2000-2017): a continuous evolution to success. Chirurgia (Bucur) 2017; 112 (03) 229-243